Inactive Instrument

Meda AB Stock

Stocks

End-of-day quote Nasdaq Stockholm
- ^SEK	-

16-07-20	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
16-07-15	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

16-07-20	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
16-07-15	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE
16-06-02	Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	RE
16-03-09	Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	RE
16-02-10	Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	RE
16-01-15	Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	RE
14-07-14	AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	RE
14-07-11	Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
14-07-11	Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
14-05-15	Banks vie for fees as Nordic deal scene ignites	RE
14-05-06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
14-05-06	Actavis : M&A frenzy in healthcare sector	RE
14-05-01	Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	RE

16-08-25	Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	BU
16-08-08	Meda : Delisting of Meda Aktiebolag (publ)	BU
16-08-05	MEDA: Notice to noteholders regarding change of control	BU
16-08-02	Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	BU
16-08-02	Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	BU

16-07-20	Mylan NV : La CE autorise Mylan à racheter Meda sous conditions
16-07-15	Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources
16-02-11	Cisco Systems : Wall Street ouvre en net recul
16-02-11	Wall Street ouvre en baisse, craintes sur la croissance mondiale
16-02-11	Meda : BOURSE-Meda s'envole de plus de 70% après son rachat par Mylan

Manager	Title	Age	Since
Lars Henrik Andreas Rejnus CEO	Chief Executive Officer	52	-
Mårten Österlund LAW	General Counsel	69	2014-12-08
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	64	2004-12-31

Director	Title	Age	Since
Colleen Ostrowski BRD	Director/Board Member	53	2016-08-24
Caroline Rebecca Louise Dixon BRD	Director/Board Member	58	2016-08-24
Lars Henrik Andreas Rejnus CHM	Chairman	52	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.52%	+2.93%	+37.52%	+105.73%	1,043B
JOHNSON & JOHNSON	+1.62%	+1.69%	+36.25%	+64.21%	618B
ABBVIE INC.	+1.35%	+5.10%	+19.73%	+85.24%	481B
MERCK & CO., INC.	+2.56%	+1.40%	+67.07%	+39.89%	351B
ROCHE HOLDING AG	+1.45%	+3.50%	+21.87%	+42.64%	338B
NOVARTIS AG	+1.17%	+2.37%	+11.71%	+35.14%	269B
ASTRAZENECA PLC	+0.89%	+1.08%	-7.28%	+10.52%	244B
AMGEN INC.	+2.18%	+3.27%	+40.89%	+53.28%	220B
GILEAD SCIENCES, INC.	+2.68%	+4.21%	+29.21%	+100.95%	182B
Average	+1.74%	+0.28%	+28.55%	+59.73%	416.3B
Weighted average by Cap.	+1.47%	+0.60%	+31.41%	+69.81%